VYGR · Voyager Therapeutics, Inc.
$3.07
+0.03 (+0.82%)
At close · Jul 29
Market Cap
$183.68M
Shares
60.42M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
131,470 shares
as of 2023-12-31
· not restated in filings since 2024-02-28
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-11-10 | $100,000,000 | — | — | — | 10-K , filed 2026-03-09 |
Key facts
CIK
1640266
CUSIP
92915B106
13F (30d)
22 filings
22 filers
Visit website
Investor relations